Kentucky Retirement Systems Insurance Trust Fund Has $742,000 Stock Holdings in The Clorox Company (NYSE:CLX)

Kentucky Retirement Systems Insurance Trust Fund increased its stake in shares of The Clorox Company (NYSE:CLX) by 24.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,570 shares of the company’s stock after buying an additional 903 shares during the period. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Clorox were worth $742,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Catalyst Capital Advisors LLC acquired a new position in shares of Clorox during the third quarter worth approximately $54,000. Los Angeles Capital Management LLC raised its position in Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after purchasing an additional 10,149 shares during the last quarter. Advisors Asset Management Inc. lifted its holdings in Clorox by 43.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock worth $4,865,000 after buying an additional 9,037 shares in the last quarter. Natixis Advisors LLC boosted its position in Clorox by 8.3% in the 3rd quarter. Natixis Advisors LLC now owns 63,476 shares of the company’s stock valued at $10,341,000 after buying an additional 4,839 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Clorox by 1.8% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company’s stock valued at $117,932,000 after buying an additional 13,038 shares during the period. Institutional investors own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Barclays upped their target price on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research report on Wednesday, February 5th. Wells Fargo & Company lifted their price target on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 4th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $158.21.

Clorox Trading Up 1.8 %

NYSE:CLX opened at $150.93 on Thursday. The business’s 50-day simple moving average is $158.38 and its 200-day simple moving average is $159.74. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The stock has a market capitalization of $18.68 billion, a PE ratio of 41.24, a price-to-earnings-growth ratio of 2.53 and a beta of 0.42.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm earned $2.16 earnings per share. Sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.